Introduction
Voglow M is a prescription medication that contains two active ingredients: Metformin and Voglibose. It is commonly prescribed to help manage blood sugar levels in individuals with type 2 diabetes.
Uses
Voglow M is primarily used to control blood glucose levels in patients with type 2 diabetes mellitus. It is often prescribed alongside a healthy diet and regular exercise to improve glycemic control.
Dosage and Administration
The dosage of Voglow M may vary depending on the individual’s medical condition and response to treatment. Follow the instructions provided by your healthcare provider. Typically, the initial recommended dose is one tablet taken orally, usually with meals. Your healthcare provider may adjust the dosage based on your blood sugar levels and response to treatment.
Mechanism of Action
Voglow M works by targeting two different mechanisms to help control blood sugar levels. Metformin reduces the production of glucose in the liver and improves insulin sensitivity in the body’s tissues. Voglibose, the other active ingredient, inhibits the breakdown of complex carbohydrates into simple sugars, thereby delaying their absorption and reducing postprandial blood glucose levels.
Side Effects
Common side effects may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal discomfort. These side effects are usually mild and transient. However, if they persist or worsen, consult your healthcare provider.
Serious side effects are rare but can occur. These may include symptoms such as severe allergic reactions, persistent nausea or vomiting, severe abdominal pain, or signs of lactic acidosis (a rare but serious condition). If you experience any of these symptoms, seek immediate medical attention.
Drug Interactions
Voglow M may interact with other medications. Inform your healthcare provider about all the medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements. Some medications, such as certain antibiotics, diuretics, or medications that affect kidney function, may interact with Voglow M and may require dosage adjustments or monitoring.
Precautions
Before starting Voglow M, inform your healthcare provider about any medical conditions you have, especially if you have a history of kidney or liver disease. Voglow M should be used with caution in patients with impaired renal function.
Inform your healthcare provider about any allergies you may have, as Voglow M may contain inactive ingredients that could cause allergic reactions.
Voglow M should not be used in individuals with type 1 diabetes or diabetic ketoacidosis. Follow your healthcare provider’s instructions and regularly monitor your blood sugar levels while taking this medication.
Storage
Patient Tips
- Take Voglow M exactly as prescribed by your healthcare provider. Do not take more or less than the recommended dose.
- maintain a healthy diet and regular exercise routine while taking Voglow M to help manage your blood sugar levels effectively.
- If you experience any side effects or have concerns while taking Voglow M, contact your healthcare provider for guidance.
- Keep regular appointments with your healthcare provider to monitor your blood sugar levels and assess the effectiveness of the medication.
- Carry a form of identification (such as a medical alert bracelet or card) to indicate that you are taking Voglow M in case of emergencies.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Metformin: a medicine to treat type 2 diabetes (NHS UK) [Accessed 10 Jun. 2024] (online) Available at:
- Competact 15 mg/850 mg film-coated tablets (Health Professionals SmPC) Available at:
- Metformin (Drugs.com) [Accessed 6 Jun. 2024] (online) Available at:
- metformin (RX) [Accessed 21 Jun. 2024] (online) Available at:
- Metformin (MedlinePlus) [Accessed 2 Jun. 2024] (online) Available at:
- LaMoia TE, Shulman GI. Cellular and Molecular Mechanisms of Metformin Action. Endocr Rev. 2021 Jan 28;42(1):77-96. doi: 10.1210/endrev/bnaa023. [Accessed 21 Jun. 2024] Available at:
Reviews
There are no reviews yet.